# OnCo record nct06419634 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06419634/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06419634", "NCT06419634" ;
  schema:name "Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome"@en ;
  schema:description "A phase 1 trial of ORM-6151 (BMS-986497) run by Bristol-Myers Squibb, terminated."@en ;
  schema:url <https://onco.cc/trials/nct06419634/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06419634> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/> ;
  onco:drugs <https://onco.cc/drugs/orm-6151/> ;
  onco:companies <https://onco.cc/companies/orum-therapeutics/>, <https://onco.cc/companies/bms/> .